Back to Search Start Over

Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences

Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences

Authors :
Susan L. Karam
Jared A. Dendy
Lawrence Blonde
Shruti Polu
Source :
Diabetes Spectr
Publication Year :
2020
Publisher :
American Diabetes Association, 2020.

Abstract

Many people with diabetes do not achieve individualized treatment targets. Therapeutic inertia, the underuse of effective therapies in preventing serious clinical end points, is a frequent, important contributor to this failure. Clinicians, patients, health systems, payors, and producers of medications, devices, and other products for those with diabetes all play a role in the development of therapeutic inertia and can all help to reduce it.

Details

ISSN :
19447353 and 10409165
Volume :
33
Database :
OpenAIRE
Journal :
Diabetes Spectrum
Accession number :
edsair.doi.dedup.....309053bf08aac4c1f71de92c02875b71
Full Text :
https://doi.org/10.2337/ds19-0029